Hi, what are you looking for?
The United Nations has designated 2025 as the year of quantum science and technology, highlighting the profound impact that technological advancements are poised to...
Mines and Money Miami, a key event for the mining industry, will take place on February 21-22, 2025, at the James L. Knight Center....
The uranium market entered 2024 on strong footing after a year of significant price movement, as well as renewed attention on nuclear energy’s role...
HIGHLIGHTS 27m @ 2.7 grams per tonne (‘g/t’) gold equivalent (AuEq.), including 12m @ 3.9 g/t AuEq. from 435m downhole in OEDD-98. 10m @...
/NOT FOR DISTRIBUTION TO UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSX Venture Exchange (TSX-V): LIT Frankfurt Stock Exchange (FSE): OAY3 OTCQX Venture Market:...
Within 24.51m of 486.30 g/t AgEq Silver47 Exploration Corp. (TSXV: AGA) (‘Silver47’ or the ‘Company), is pleased to announce the first results from the...
Group Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) is pleased to announce its participation at the upcoming New Orleans Investment Conference on Saturday,...
Gunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional open-pit and...
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b...
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release...
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the...